MEMORI Corps: A novel activity-based companion care program to benefit community-living persons with dementia, their families, and senior volunteers
MEMORI Corps:一项新颖的基于活动的陪伴护理计划,旨在造福社区生活的痴呆症患者、他们的家人和老年志愿者
基本信息
- 批准号:10434037
- 负责人:
- 金额:$ 70.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-30 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:2 arm randomized control trialAcademyAddressAlzheimer&aposs DiseaseBehaviorBehavioral SymptomsCaregiversCaringChildChronicClinicalCognitionCommunicationCommunitiesCompanionsCoupledDementiaEffectivenessEvidence based interventionFamilyFamily CaregiverFinancial HardshipFutureGoalsHealthHealth BenefitHomeHourIntensive CareInterventionLearningLearning SkillLong-Term CareMental DepressionModelingNursing HomesOutcomePatientsPersonsPhysical FunctionPositioning AttributeProblem behaviorProductivityPublic HealthQuality of lifeRandomizedRandomized, Controlled TrialsReportingResourcesRiskServicesSignal TransductionSingle-Blind StudySocial isolationStructureSupervisionTechniquesTestingTimeTrainingUnited States National Institutes of HealthWagesWaiting ListsWorkacceptability and feasibilitycare coordinationcaregiver educationcaregivingcommunity livingcostdementia caredepressive symptomsdesignefficacy evaluationelementary schoolemotional distressevidence baseexperiencefamily caregivingfamily supportfunctional declinefunctional disabilityimprovedimproved outcomeinformal caregiverinterestintergenerationalmedical complicationmultidisciplinaryneuropsychiatric symptomnovelnovel strategiespeer supportpreservationprimary endpointprogramspsychologicpsychosocialrandomized trialrespite careskillssocialsocial engagementsocial modelstakeholder perspectivestrendvolunteer
项目摘要
PROJECT SUMMARY/ABSTRACT
Dementia is a high cost, high burden public health challenge. These include needs for respite and relief for the
family, behavior management, supervision, and meaningful activities for the person with dementia (PWD).
Family caregivers (CG) provide most of the care required, yet demographic trends project a steep decline in
the availability of such CGs—signaling a looming crisis. A changing CG demographic (e.g. younger
caregivers, caring for multiple persons while working) will also contribute to shortages in availability. Previously
proven psychosocial and skill-building interventions are important care strategies to improve outcomes, but are
also time intensive for caregivers to learn and implement. Also, these interventions do not typically afford
family CGs with respite opportunities—a nearly universal need. Thus, new approaches to supporting families
living with dementia are urgently needed.
This is a randomized controlled trial (NIH Stage III) to evaluate the feasibility and efficacy of Making
Engagement Meaningful through Organized Routine Interaction (MEMORI) Corps, a novel activity-based
companion care model delivered in the home to community-living persons with dementia (PWD) and their
family caregivers (CG) by trained and supervised senior volunteers vs. Augmented Waitlist Control. The goal
of the program is to address unmet respite care needs for dementia family caregivers, provide persons with
dementia meaningful evidence-based activity programming, as well as provide health benefits, meaningful
productive engagement, and peer support opportunities for senior volunteers. Core intervention components
are derived and synthesized from Tailored Activities Program® , Experience Corps® and MIND at Home®
and include: (1) detailed initial home-based assessment of interests and preserved abilities of PWD; (2)
individualized activity program plans based on interests and abilities; (3) training of volunteers in
communication and simplification strategies and use of activity program plans; (4) delivery of activity plans by
volunteers to PWD over 12 weeks (8 hours/week) in their homes; (5) family caregiver education on activity
plans and ways to utilize respite opportunities; and (6) support of volunteers from a skilled multidisciplinary
clinical team. PWD/CG outcomes will be assessed at BL, 6-, and 12-weeks (PWD/CG participation lasts 12
weeks). Volunteer outcomes will be assessed at 6- and 12-months (Volunteer participation lasts 12 months).
This model program could serve as an important new advancement for community-based long term care for
PWD that addresses unmet patient- and family-centered needs through civic engagement of seniors.
项目概要/摘要
痴呆症是一项高成本、高负担的公共卫生挑战,其中包括需要喘息和缓解。
痴呆症患者 (PWD) 的家庭、行为管理、监督和有意义的活动。
家庭护理人员 (CG) 提供大部分所需护理,但人口趋势预计家庭护理人员数量将急剧下降
此类 CG 的可用性——预示着一场迫在眉睫的 CG 人群变化(例如年轻人)。
护理人员(在工作时照顾多人)也将导致供应短缺。
行之有效的心理社会和技能建设干预措施是改善结果的重要护理策略,但
护理人员学习和实施的时间也很密集,而且这些干预措施通常负担不起。
提供喘息机会的家庭CG几乎是普遍的需求,因此需要新的方法来支持家庭。
迫切需要患有痴呆症的人。
这是一项随机对照试验(NIH III 期),旨在评估制造的可行性和有效性
通过有组织的日常互动 (MEMORI) Corps 实现有意义的参与,这是一种新颖的基于活动的
在家中为社区生活的痴呆症患者 (PWD) 及其家人提供陪伴护理模式
由经过培训和监督的高级志愿者组成的家庭看护者 (CG) 与强化候补名单控制 目标。
该计划的目的是解决痴呆症家庭护理人员未得到满足的暂托护理需求,为人们提供
痴呆症有意义的循证活动规划,以及提供健康益处,有意义
为高级志愿者提供富有成效的参与和同伴支持机会。
源自并综合于 Tailored Activity Program®、Experience Corps® 和 MIND at Home®
包括:(1) 对残疾人的兴趣和保留能力进行详细的初步评估;(2)
(三)志愿者培训
(四)活动计划的交付
志愿者在家中为残疾人提供超过 12 周(每周 8 小时)的服务;(5) 家庭看护者活动教育;
利用暂息机会的计划和方法;以及 (6) 来自熟练的多学科志愿者的支持
临床团队将在 BL、6 周和 12 周时评估 PWD/CG 的结果(PWD/CG 参与持续 12 周)。
志愿者成果将在 6 个月和 12 个月时进行评估(志愿者参与持续 12 个月)。
该模型计划可以作为基于社区的长期护理的重要新进步
PWD 通过老年人的公民参与来解决未满足的以患者和家庭为中心的需求。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Quincy Miles Samus其他文献
Quincy Miles Samus的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Quincy Miles Samus', 18)}}的其他基金
Pilot Core (AD/ADRD Focus): Technology Development and Refinement
试点核心(AD/ADRD 重点):技术开发和完善
- 批准号:
10491905 - 财政年份:2021
- 资助金额:
$ 70.14万 - 项目类别:
Pilot Core (AD/ADRD Focus): Technology Development and Refinement
试点核心(AD/ADRD 重点):技术开发和完善
- 批准号:
10683478 - 财政年份:2021
- 资助金额:
$ 70.14万 - 项目类别:
Pilot Core (AD/ADRD Focus): Technology Development and Refinement
试点核心(AD/ADRD 重点):技术开发和完善
- 批准号:
10688423 - 财政年份:2021
- 资助金额:
$ 70.14万 - 项目类别:
Pilot Core (AD/ADRD Focus): Technology Development and Refinement
试点核心(AD/ADRD 重点):技术开发和完善
- 批准号:
10688572 - 财政年份:2021
- 资助金额:
$ 70.14万 - 项目类别:
Pilot Core (AD/ADRD Focus): Technology Development and Refinement
试点核心(AD/ADRD 重点):技术开发和完善
- 批准号:
10274376 - 财政年份:2021
- 资助金额:
$ 70.14万 - 项目类别:
Pilot Core (AD/ADRD Focus): Technology Development and Refinement
试点核心(AD/ADRD 重点):技术开发和完善
- 批准号:
10683462 - 财政年份:2021
- 资助金额:
$ 70.14万 - 项目类别:
Pilot Core (AD/ADRD Focus): Technology Development and Refinement
试点核心(AD/ADRD 重点):技术开发和完善
- 批准号:
10678978 - 财政年份:2021
- 资助金额:
$ 70.14万 - 项目类别:
Pilot Core (AD/ADRD Focus): Technology Development and Refinement
试点核心(AD/ADRD 重点):技术开发和完善
- 批准号:
10683470 - 财政年份:2021
- 资助金额:
$ 70.14万 - 项目类别:
MEMORI Corps: A novel activity-based companion care program to benefit community-living persons with dementia, their families, and senior volunteers
MEMORI Corps:一项新颖的基于活动的陪伴护理计划,旨在造福社区生活的痴呆症患者、他们的家人和老年志愿者
- 批准号:
10224077 - 财政年份:2018
- 资助金额:
$ 70.14万 - 项目类别:
相似国自然基金
“抗疫精神”对医护职业偏好、行为偏好的短期与长期影响:基于医务人员和医学院学生的研究
- 批准号:72173093
- 批准年份:2021
- 资助金额:48 万元
- 项目类别:面上项目
湖州师范学院理论物理强子共振态和核物理方向学术交流与平台建设
- 批准号:
- 批准年份:2021
- 资助金额:50 万元
- 项目类别:
数学院士专家大学中学系列科普活动
- 批准号:12026425
- 批准年份:2020
- 资助金额:20.0 万元
- 项目类别:数学天元基金项目
湖州师范学院理论物理奇特核结构与反应方向学术交流与平台建设
- 批准号:
- 批准年份:2020
- 资助金额:50 万元
- 项目类别:专项基金项目
湖州师范学院基于HIRFL-CSR和HIAF的核物理理论发展和交流平台
- 批准号:
- 批准年份:2019
- 资助金额:50 万元
- 项目类别:专项基金项目
相似海外基金
Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study
度洛西汀预防奥沙利铂引起的化疗引起的周围神经病变:一项随机、双盲、安慰剂对照的 II 期至 III 期研究
- 批准号:
10322762 - 财政年份:2019
- 资助金额:
$ 70.14万 - 项目类别:
Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study
度洛西汀预防奥沙利铂引起的化疗引起的周围神经病变:一项随机、双盲、安慰剂对照的 II 期至 III 期研究
- 批准号:
10543540 - 财政年份:2019
- 资助金额:
$ 70.14万 - 项目类别:
Evaluation of the efficacy and mechanisms of a novel intervention for chronic pain tailored to people living with HIV
评估针对艾滋病毒感染者量身定制的慢性疼痛新型干预措施的功效和机制
- 批准号:
10397398 - 财政年份:2018
- 资助金额:
$ 70.14万 - 项目类别:
Evaluation of the efficacy and mechanisms of a novel intervention for chronic pain tailored to people living with HIV
评估针对艾滋病毒感染者量身定制的慢性疼痛新型干预措施的功效和机制
- 批准号:
9922384 - 财政年份:2018
- 资助金额:
$ 70.14万 - 项目类别: